Stockreport

Edgewise gets EU orphan drug status for muscular dystrophy drug [Seeking Alpha]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF Sevasemten, also known as EDG-5506, is in Phase 3 testing for Becker and Phase 2 testing for Duchenne, according to the company's website. The FDA has granted the pro [Read more]